Birdwatch Note Rating
2023-03-16 07:43:48 UTC - NOT_HELPFUL
Rated by Participant: 2E205AF78E85C34F643D6F52E3504006AFF3277B72CB0DAB02995475853F1859
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details